At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 87 enrolled
Drug / intervention
Simethicone Solution +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Effects of Simethicone and Vivatlac Baby in Infantile Colic
The President Stanisław Wojciechowski State University of Applied Sciences in Kalisz·interventional·Posted Jul 27, 2020·Updated Nov 22, 2023
In Brief
A Phase 2 clinical trial evaluating Simethicone Solution and Vivatlac Baby for Infantile Colic. Completed, enrolled 87 participants across 2 sites.
Detailed Summary
Open trial with two parallel arms, assessing the effects of Simethicone and Vivatlac Baby in babies diagnosed for infantile colic.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsInfantile Colic
CountriesPoland
Collaborators--
Timeline
Phase 2CompletedFinished
202120222023202420252026
Enrollment StartApr 2020
Primary CompletionJun 2020
First PostedJul 2020
TodayJul 2026
First PostedJul 27, 2020
Enrollment StartApr 16, 2020
Primary CompletionJun 30, 2020
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 5.9 years ago
Interventions
Simethicone Solutiondrug
Oral daily treatment for four weeks
Vivatlac Babydietary
Oral daily treatment for four weeks